SCHEMBL18480730

SCHEMBL18480730

CCCC(C)C(C)C(C)C(C)NCC

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20714587 0.93 METAP1 (0.31) METAP1
SCHEMBL24722286 0.82 METAP1 (0.33) METAP1
SCHEMBL19063319 0.82 METAP1 (0.33) METAP1
SCHEMBL22064767 0.80
SCHEMBL20609967 0.73 TSHR (0.40) METAP1
SCHEMBL24925671 0.72
SCHEMBL20609978 0.71 METAP1 (0.36) METAP1
SCHEMBL21440306 0.70 DNM1 (0.36)
SCHEMBL22641435 0.70 METAP1 (0.32) METAP1
SCHEMBL20928522 0.70 METAP1 (0.32) METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017023989-A1 3-(1H-BENZO[D]IMIDAZOL-2-YL)-1H-PYRAZOLO[4,3-B]PYRIDINES AND THERAPEUTIC USES THEREOF SAMUMED, LLC. (US) 2017-02-09 WO disclosed